Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity

Initially developed to treat patients with type 2 diabetes, these drugs also cause significant weight loss and are establishing themselves as the first truly effective pharmacological treatments for obesity.